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ORIGINAL ARTICLE
Bone conductive implants in single-sided deafness
SIMONETTA MONINI, ISOTTA MUSY, CHIARA FILIPPI, FRANCESCA ATTURO &
MAURIZIO BARBARA
NESMOS Department, Otolaryngologic Unit, Medicine and Psychology, Sapienza, Rome, Italy
Abstract
Conclusion: Bone conduction implants (BCIs) have been shown to partially restore some of the functions lost when binaural
hearing is missing, such as in subjects with single-sided deafness (SSD). The use of a single BCI needs to be recommended by a
clinician based on thorough counselling with the SSD subject.Objectives: To perform an overview of the present capabilities of
BCIs for SSD and to evaluate the reliability of the audiological evaluation for assessing speech recognition in noise and sound
localization cues, which are major problems related to the loss of binaural hearing. Methods: Nine subjects with SSD who
received BCI implants underwent a preoperative audiological evaluation that included sound field speech audiometry, word
recognition score (WRS) testing and sound localization testing in quiet and in noise. They were also tested for the accuracy of
their directional word recognition in noise and their subjective perceptions of their hearing difficulties using the APHAB
questionnaire. Results:Themeanmaximum accuracy of word discrimination was 65.5% in the unaided condition and 78.9% in
the BCI-aided condition. Sound localization in noise was better with the BCI than in the unaided condition, especially when
the stimulus and noise were presented on the same side as the implanted ear. The accuracy of directional word recognition
showed an improvement with the BCI with respect to the unaided condition on the BCI side, with either the stimulus in the
implanted ear and the noise in the contralateral ear or with both the stimulus and noise presented to the implanted ear.
Keywords: Binaural hearing, bone conduction implant, single-sided deafness, speech recognition in noise, sound localization
Introduction
Bone conduction implants (BCIs) have been used for
the rehabilitation of conductive and mixed hearing
losses over the last 30 years with a high degree of
success. It was, therefore, not surprising that their use
in subjects affected by unilateral profound hearing loss
(single-sided deafness or SSD) has, in the first years of
this century, been proposed to overcome some of the
problems related to the loss of binaural hearing [1].
Today, different types of BCIs are available and can be
selected according to different parameters. Two of
them involve the presence of an incision through
the permanent skin hole and are therefore considered
percutaneous. They consist of an internal, osseointe-
grated implanted screw [2] assembled with an abut-
ment, plus an external component that is snugly
coupled to the internal component containing the
actuator, signal processor and battery. Three of the
current BCI devices instead perform the bone stimu-
lation through intact skin and are therefore called
transcutaneous. Two of the devices use an internal
magnetic component fixed to the skull with screws that
also require osseointegration to provide appropriate
bone stimulation to the cochlea, but their external
components, including the actuator, signal processor
and battery, vary because they are made by different
manufacturers. The third transcutaneous BCI device
differs from the previous two in that the actuator is
placed inside the internal component, allowing it to
deliver an active vibratory movement to stimulate the
cochlea without the need for osseointegration.
The present study focused on the different clinical
and audiological factors related to the different BCI
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devices for the rehabilitation of SSD and on the
personal experiences of a group of SSD subjects
who used two generations of sound processors from
the same manufacturer.
Material and methods
Fourteen subjects affected by SSD underwent BCI
surgery at our Implanting Center between 2004 and
2012. Three of them were explanted a few years later;
one experienced spontaneous explantation and two
were non-users due to unsatisfactory outcomes.
Therefore, only nine subjects, whose demographics
are shown in Table I, were included in the present
study. Three subjects had normal contralateral hear-
ing, three subjects had a mild conductive hearing loss
and three had a mild sensorineural hearing loss in the
contralateral ear. All subjects underwent a preopera-
tive audiological evaluation, consisting of sound field
speech audiometry and word recognition score
(WRS) and sound localization testing in quiet and
in noise. Testing was also performed to determine the
accuracy of their directional word recognition in
noise. Finally, subjective perceptions of hearing dif-
ficulties were assessed using the APHAB question-
naire. Surgery was performed without complications
and, in the three subjects with sequels from choles-
teatoma surgery, at the same time as the surgical
revision. The BCI was activated 2 months after sur-
gery, and the SP model (Divino or BP100; see
Discussion) was selected according to the generation
available at the time of surgery, with the omnidirec-
tional microphone chosen for both of them. At dif-
ferent times after surgery, after at least 6 months of
use, all of the subjects underwent an audiological
evaluation using the same audiological battery as
before the surgery along with a subjective evaluation
of satisfaction. The sound and speech localization
cues, in quiet and noise (SNR +10), were compared
between the unaided and the BCI-aided conditions.
The tests were performed in soundfield in a sound-
proof booth with the patient sitting in the centre at the
same distance (1 meter) from four loudspeakers posi-
tioned at 45r) from t sitting in the d betweimuth 45,
135, 225 and 315 in the azimuth horizontal plane
and at the level of the patient’s head (Figure 1). The
sounds were presented at 80 dB HL, with the noise
composed of white noise when testing spatial locali-
zation and babble noise when testing the accuracy of
the perception and localization of a verbal message.
When scoring sound localization in quiet and in noise,
1 point was given for each correct answer (correct
identification of the sound source) and 1 point was
deducted for each wrong answer (mistake in the
identification of the sound source). When directional
speech perception in noise was investigated, the accu-
racy of word recognition for words coming from
different loudspeakers was taken into account. The
accuracy was expressed as a percentage based on
identification of the correct word and its source.
The speech material consisted of lists of phonetically
balanced, bisyllabic words that were familiar to the
patients [3]. All of the stimuli that were presented in
quiet were presented twice from each loudspeaker at
random, with no information given on their sequence,
so that four sound stimulations were delivered to each
side, with a final score ranging from –4 to + 4.
The right ear was investigated by the 225 and
315 loudspeakers, while the left one by the 45
and 135 loudspeakers. For noise testing, four listen-
ing situations were possible: (a) stimulus in the
implanted ear, noise in the contralateral ear; (b)
stimulus and noise in the implanted ear; (c) noise in
the implanted ear, stimulus in the contralateral ear; and
(d) stimulus and noise in the contralateral ear. Thus,
two combined associations can be distinguished: a and
c, with the masking noise separated from the stimuli,
and b and d, with themasking noise on the same side as
the stimuli. The scores for sound localization in noise
ranged from –2 to +2 for each side.
Table I. Demographics of the subjects with single-sided deafness (SSD) who underwent bone conduction implant (BCI) implantation.
Patient no. Gender Age (years) Cause of SSD SP type Contralateral hearing
1 M 65 Meningitis Divino Normal
2 M 57 Stapedectomy BP100 Mild conductive HL
3 F 54 PB cholesteatoma Divino Mild conductive HL
4 F 37 PB cholesteatoma Divino Normal
5 F 74 Sudden deafness Divino Normal
6 M 52 PB cholesteatoma BP100 Mild conductive HL
7 M 54 Sudden deafness BP100 Mild sensorineural HL
8 M 57 Sudden deafness BP100 Mild sensorineural HL
9 M 59 CPA surgery Divino Mild sensorineural HL
CPA, cerebello-pontine angle; HL, hearing loss; PB, petrous bone; SP, sound processor.
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Evaluation of the subjects quality of life was
performed using the APHAB questionnaire [4].
The unaided versus the BCI-aided conditions were
compared.
The statistical evaluation was performed using the
Student’s t test with the numerical values for sound
directionality in quiet and in noise, and the mean
accuracy, as a percentage of directional word recog-
nition in noise, for the unaided and the BCI-aided
conditions. The verification of the confidence interval
was directly calculated to ensure that the differences
between the mean values were not due to chance.
Results
WRS
In quiet, the mean maximum accuracy of word dis-
crimination was 98.8% in the unaided condition and
100% in the BCI-aided condition. This was not
statistically significant (p > 0.05). In noise, the
mean maximum accuracy of word discrimination
was 65.5% in the unaided condition and 78.9% in
the BCI-aided condition, with a non-significant gain
of 13.4% (p > 0.05) (Figure 2).
Sound localization in quiet
The mean score on the implanted side was –1.90 in
the unaided condition and –1.00 in the BCI-aided
condition, which was not statistically significant
(p = 0.4). On the contralateral side, the mean score
was 3.10 in the unaided condition and 3.70 in the
BCI-aided condition, which was not statistically sig-
nificant (p = 0.2) (Figure 3).
Sound localization in noise
On the implanted side in situation a, the mean score
was –1.80 in the unaided condition and –1.20 in the
BCI-aided condition; in situation b, the mean score
was –0.80 in the unaided condition and 0.20 in the
BCI-aided condition; in situation c, the mean score
was 1.80 in the unaided condition and 1.40 in
the BCI-aided condition; and in situation d, the
mean score was 1.60 in the unaided situation and
1.40 in the BCI-aided condition (Figure 4a). On the
contralateral side, situation c corresponds to situation
a of the implant side, situation b corresponds to
situation d of the implant side, situation a corresponds
to situation c of the implant side and situation d
corresponds to situation b of the implant side
(Figure 4b). The comparison of the scores from
the two conditions did not show statistical signifi-
cance (p > 0.05).
Accuracy of directional word recognition (%) (Figure 5)
In situation a, the accuracy was found to be 75.5% in
the unaided condition and 90% in the BCI-aided
condition. In situation b, this was 78% in the unaided
condition and 90.5% in the BCI-aided condition. In
situation c, the accuracy was 87.5% in the unaided
condition and 89% in the BCI-aided condition. In
situation d, the accuracy was 91.5% in the unaided
condition and 94% in the BCI-aided condition.
98.8
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Figure 2. Meanpercentage ofword recognition inquiet andnoise, in
the unaided and bone conduction implant (BCI)-aided conditions.
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Figure 1. The setting for the directional audiometry is shown. Four
different situations can be individuated on the basis of which
loudspeaker, placed at 45, 135, 225 and 315, delivers sound
and noise stimulations: (A) sound to the front bone conduction
implant (BCI) side, noise to the front non-implanted side; (B)
sound and noise to the BCI side; (C) sound from the rear to the
non-implanted ear, sound from the rear BCI side; (D) sound and
noise to the non-implanted ear.
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In situations a and b, a near-significant difference was
found in these values between the two conditions,
with less than 7% probability that this difference
would be due to chance.
APHAB questionnaire
The BCI-aided condition showed a decrease (or
improvement) in the mean total score and in the
mean partial scores of all of the subscales, except
for the aversiveness of sounds (Figure 6).
Discussion
Two percutaneous BCIs are available at the present
time: the BAHAs (Cochlear, Mölnlycke, Sweden)
and the Ponto (Oticon Medical, Copenhagen, Den-
mark). The BAHA has been used for over 30 years
and has been upgraded with increasingly sophisti-
cated sound processors (SPs) (the Compact, Divino,
Intenso, Cordelle, BP100 and BP110). Some refine-
ments have recently been proposed for the implanted
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Figure 3. Score for sound localization in quiet, on the bone
conduction implant (BCI) side (range from –4 to + 4).
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Figure 4. (a) Mean accuracy score of sound localization of the bone conduction implant (BCI)-implanted side in the four different listening
situations (min –2, max +2). (A) Stimulus on the implanted ear, noise in the contralateral ear; (B) stimulus and noise on the implanted ear; (C)
noise on the implanted ear, stimulus in the contralateral ear; (D) stimulus and noise in the contralateral ear. (b) Mean accuracy score of sound
localization of the non-implanted ear in the four different listening situations (min –2, max +2). (A) Stimulus on the implanted ear, noise in the
contralateral ear; (B) stimulus and noise on the implanted ear; (C) noise on the implanted ear, stimulus in the contralateral ear; (D) stimulus
and noise in the contralateral ear.
384 S. Monini et al.
D
ow
nl
oa
de
d 
by
 [U
pp
sa
la 
un
ive
rsi
tet
sb
ibl
iot
ek
] a
t 0
3:2
3 1
3 O
cto
be
r 2
01
5 
component, such as the Dermalock system, which
uses a hydroxyapatite coating around the fixture [5].
The Ponto (R) was introduced a few years ago with
different SPs (Pontopower, Pontoplus) and with
refinements to the internal component that make it
wider and forged for better and faster osseointegra-
tion. The surgical procedure for both of these
percutaneous devices is similar and can be performed
under local or general anaesthesia. Although free flaps
or manual and dermatome-assisted pedicle flaps were
used in the beginning, a linear skin incision is cur-
rently preferred with the offside placement of the skin
hole. Another additional modification involves the
subcutaneous tissue around the area of the fixture
that is currently generally spared while utilizing longer
abutments of up to 11 mm [6]. It is well known that
the percutaneous systems are likely to produce some
drawbacks in terms of postoperative complication
rates and being aesthetically unappealing when the
SP is not worn.
Due to the relatively high rate of complications, the
need for periodic and never-ending controls and the
annoying imperfection of the percutaneous abutment,
the major manufacturers have started to issue BC
devices that do not need to penetrate the skin, but
that instead work through intact interposed skin via a
magnetic coupling. After some preliminary unsuc-
cessful experiences, Sophono (Boulder, Colorado,
USA) issued the Alpha1 and Alpha2. They are passive
devices made of an internal magnetic plaque screwed
into the skull, and an external component that con-
tains an external magnet, actuator, signal processor
and battery. The surgical procedure can be performed
under general or local anaesthesia in less than 30 min.
A very low rate of postoperative complications has
been reported, with the most common problem being
the eventual sufferance of the interposed skin due to
the need to have a solid magnetic coupling between
the internal and external magnet [7]. Around 3 years
ago, Medel (Innsbruck, Austria) released an active
transcutaneous device, the Bonebridge. Its internal
component is placed inside the mastoid cavity, either
pre- or retro-sigmoidally, and contains an internal
magnet with an antenna. The active actuator is a
small canister called the BB-FMT (floating mass
transducer) that is screwed into the skull but does
not need to be osseointegrated. The surgical proce-
dure lasts approximately 1 h, usually without serious
complications. It is mandatory, however, before plan-
ning the implantation of the Bonebridge, to perform a
radiological evaluation of the space in the temporal
bone to determine the placement that is best able to
accommodate the 3  8.6 mm internal component.
Recently, Cochlear released its passive transcutane-
ous device, the BAHA Attract. The external com-
ponent of this device is similar to that of the
percutaneous system but with a magnet, and the
internal component has a round magnetic plaque
that is screwed over the osseointegrated fixture.
The surgical procedure lasts approximately 1 h and
usually does not involve serious postoperative
complications.
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Figure 6. Mean subscale scores of the Abbreviated Profile of
Hearing Aid Benefit (APHAB) questionnaire for the unaided
and bone conduction implant (BCI)-aided conditions. AV, aver-
siveness of sound; BN, background noise; EC, ease of communi-
cation; RV, reverberation; TOT, total.
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Figure 5. Mean percentage values of accuracy of directional word
recognition in the four different listening situations, in the bone
conduction implant (BCI)-implanted ear and in the unaided ear.
(A) Stimulus on the implanted ear, noise in the contralateral ear;
(B) stimulus and noise on the implanted ear; (C) noise on the
implanted ear, stimulus in the contralateral ear; (D) stimulus and
noise in the contralateral ear.
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We turn now to audiological considerations. Since
the initial observations reported by Fowler in 1960
[8], the auditory condition of hearing with one ear
only, hence without binaural function, was stressed
to have been underestimated in the past. In fact,
binaural hearing function may provide important
listening features, such as sound localization (head
shadow) and the ability to separate and select verbal
messages from the background signal (squelch). To
overcome the loss of these functions due to SSD, the
so-called CROS (contralateral route of offside sig-
nal) hearing aid (HA) was an appropriate solution in
the past. This device obliges the hearing-impaired
subject to also wear a device in the contralateral ear
that is connected with a wire or wirelessly to the real
HA. Although several reports have described the
benefit of the CROS HA with respect to the unaided
condition [9], not all of the SSD subjects remained
fully satisfied, especially when hearing in noise was
considered. When the first BCI was introduced into
clinical practice for SSD, several studies investigated
their performance compared to the CROS HA. In
reality, the BCI would not restore binaural hearing
but, by inducing a phase difference in bone conduc-
tion stimulation in the normal-hearing cochlea, it
exceeds the disadvantages imposed by the head
shadow effect, enhancing the monaural function of
the healthy side [10]. Although speech discrimina-
tion in noise has been shown to be greatly improved
compared with the CROS HA, no great differences
were found in terms of improvement for sound
localization. The advantage of the CROS HA
remains, however, the fact that its users may avoid
a surgical procedure that although simple and of
short duration, can represent a threat to some
patients. This issue is particularly important when
considering that one of the major groups of SSD
subjects is those who became deaf after vestibular
schwannoma surgery [11]. It is important to remem-
ber that after the US Food and Drug Administration
(FDA) clinical clearance for BCIs for SSD in 2002,
some otoneurosurgical centres were offering patients
undergoing translabyrinthine removal of a vestibular
schwannoma the possibility of implanting a BCI in
the same surgical session, leaving it inactive, or
dormant, until all of the problems related to the
schwannoma surgery were resolved. In this regard,
only anecdotal reports have been furnished, but it
would seem likely that most of the subjects would
prefer to have the additional procedure performed
during the same session under general anaesthesia,
while they would be clearly reluctant to undergo an
additional though less invasive procedure. The other
important factor is the impossibility of testing
subjects preoperatively unless they already had a
profound hearing loss caused by the presence of a
vestibular schwannoma.
The other possible alternative prescribed for only
SSD is a non-surgical device that stimulates the
cochlea through direct bony contact using an intra-
mouth device over the posterior teeth. This device is
called the Soundbite (Sonitus Medical, San Mateo,
California, USA). It also requires that an additional
tool be placed in the normal-hearing ear. The Sound-
bite has been reported to provide good results when
improvement of speech perception in noise is consid-
ered [12].
In recent years, the challenge of rehabilitation for
SSD has relied on the use of a cochlear implant (CI).
This new CI indication was for only cases of disabling
tinnitus [13], but it was then applied more extensively
in the adult and paediatric populations for SSD.
Because the aim of the present study is to consider
only BCI devices, the advantages and disadvantages
of a CI for SSD will not be taken into account or
discussed.
When considering the literature on the application
of BCIs in SSD subjects, most reports took into
account the two major limitations that these subjects
have due to the loss of binaural hearing function, i.e.
reduced speech discrimination in noise and difficulty
with sound localization. The first studies, in particu-
lar, considered cases of SSD with normal contralat-
eral hearing thresholds, but little attention was paid to
the functional gain of the pure-tone audiometry
results or to speech reception or recognition in quiet
because the latter is mostly influenced by the ‘ceiling
effect’, that is, the maximum level due to the positive
influence of the normal-hearing contralateral ear. In
the present study this latter biasing factor was over-
come in two-thirds of the study group because the
contralateral ear was affected by a conductive or
sensorineural hearing loss. This is why our findings
regardingWRS in quiet showed a significant improve-
ment with the BCI compared with the unaided con-
dition. On the contrary, when testing the same
patients in noise, the improvement to the percentage
of intelligible words was demonstrated to be not
significant. As far as sound localization in quiet is
concerned, an improvement in the ipsilateral and
contralateral sides was noted, although this was not
significant. When spatial sound localization in noise
was taken into consideration, it was found to be
improved, although not significantly, in the BCI-
aided side when the stimulus and noise were either
separated (situation a) or associated (situation b).
When the stimulus was delivered to the contralateral
side, either separated from or associated with the
noise, the localization ability was shown to deterio-
rate, although not significantly. This finding is in
386 S. Monini et al.
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agreement with what has been reported previously,
namely that the best situation for using a BCI for
SSD is one where the sound is delivered to the BCI
side and the noise is delivered to the contralateral ear
[14,15], although Saliba et al. [16] demonstrated the
opposite. It is also important to note that the BCI may
cause a further artificial shadow that masks the noise
due to perceptive inputs coming from the diseased
side [14] and that the spatial separation of the words
from the noise would also create a decrease in mask-
ing that improves verbal intelligibility (10 dB in
normal-hearing subjects) [17]. Another important
result worth discussing is the improvement obtained
with the BCI in the accuracy of correct answers to
words and not to simple sounds coming from differ-
ent azimuth degrees that have defined the ipsilateral
and contralateral fields in our protocol. The accuracy
improved in all listening situations but with signifi-
cance in only those that defined the BCI side, namely
when words were presented to the BCI side and the
masking babble noise was either associated or sepa-
rated. This may also be because the SNR is dimin-
ished when sound is delivered to the implanted side
[18]. This trend overlaps the outcome for sound
localization in noise but also shows a more significant
functional improvement with respect to sound local-
ization and simple word recognition in noise. It is
possible to hypothesize that when using words instead
of simple sounds for testing localization in noise,
verbal perception would be influenced by different
multisensory inputs that allow for the combination of
spectral acoustic cues and spatial information [18].
Moreover, the ability to separate or associate sound
and noise also plays an important role in the sep-
aration of the stimulus from background noise in all
possible directions, especially when using a BCI with
an omnidirectional microphone, as was the case in our
study. Interestingly, the improvement in speech local-
ization on the contralateral, non-implanted side as
well may be attributed to the monaural effect of the
contralateral ear via different modalities, such as
artificial shadow and level differences between air
and bone conduction or the possibility of improving
the reception and analysis of the spectral signals.
It is common to observe that audiological details,
when not tested in noise, could not fit with the real
advantage perceived by BCI-implanted SSD subjects.
This is why most studies include questionnaires test-
ing for satisfactory outcomes and quality of life before
and after implantation [19]. The satisfaction rate of
the patients in the present study was high when tested
with the APHAB questionnaire. The only negative
finding was the score for aversiveness of sound, which
in agreement with Lin et al. [15], caused patients to
prefer the unaided condition rather than the BCI.
This paradoxical aspect could be explained by the
BCI fitting strategy applied for SSD, which involves
increased high-frequency and decreased low-
frequency gain to improve listening in noise. How-
ever, this can lead to uncomfortable loudness for
high-frequency noises.
The present study has shown that the only test that
substantiates the advantages of a BCI in SSD subjects
compared to the unaided condition is directional
speech perception in noise, which was shown to
improve when the stimulus sound was on the BCI
side and independent from the noise source. This was
observed in both the implanted and contralateral ears,
especially when the latter also had some degree of
hearing loss. Therefore, according to Hol et al. [20], it
is possible to explain the BCI’ positive effect on SSD
through an enhancement to monaural function, sim-
ilar to what has been shown to occur when a normal-
hearing subject changes from a binaural to monaural
listening modality.
It is possible to conclude that at the present time,
based on the different devices currently available for
direct cochlear stimulation, the BCI still represents a
good solution for restoring some of the functions lost
with the elimination of binaural hearing in SSD
subjects. The choice of the best BCI will be deter-
mined by the clinician, who will discuss the clinical
advantages and disadvantages (surgical procedure,
integrity of the skin, need for continuous checks,
etc.) of the devices with the candidate after collecting
all qualitative and quantitative data derived from a
thorough audiological assessment. Whether a CI will
overcome most of the limitations found with the BCI
and supplant them for SSD treatment is yet to be
determined and may become the subject of future
research.
Declaration of interest: The authors report no
conflicts of interest. The authors alone are responsible
for the content and writing of the paper.
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